Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Mereckiene, J."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-25 z 82
Tytuł:
Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009?
Autorzy:
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland; Vaccine European New Integrated Collaboration Effort (VENICE) Project, Italy. jolita.mereckiene@hse.ie
Cotter S
Lopalco P
D'Ancona F
Levy-Bruhl D
Giambi C
Johansen K
Dematte L
Salmaso S
Stefanoff P
O'Flanagan D
Źródło:
Vaccine [Vaccine] 2010 Jun 17; Vol. 28 (28), pp. 4470-7. Date of Electronic Publication: 2010 May 06.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis B/*prevention & control
Hepatitis B Vaccines/*administration & dosage
Immunization Programs/*statistics & numerical data
Cross-Sectional Studies ; European Union/statistics & numerical data ; Hepatitis B/epidemiology ; Humans ; Iceland/epidemiology ; National Health Programs/statistics & numerical data ; Norway/epidemiology
Czasopismo naukowe
Szczegóły
Tytuł:
The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.
Autorzy:
Dorleans F; Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France. />Giambi C
Dematte L
Cotter S
Stefanoff P
Mereckiene J
O'Flanagan D
Lopalco PL
D'Ancona F
Levy-Bruhl D
Corporate Authors:
VENICE 2 project gatekeepers group
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2010 Nov 25; Vol. 15 (47). Date of Electronic Publication: 2010 Nov 25.
Typ publikacji:
Evaluation Study; Journal Article
MeSH Terms:
Immunization Programs/*organization & administration
Mass Vaccination/*statistics & numerical data
Papillomavirus Infections/*prevention & control
Papillomavirus Vaccines/*administration & dosage
Adolescent ; Child ; Decision Making ; Europe ; Female ; Health Policy ; Health Surveys ; Humans ; Immunization Programs/trends ; Immunization Schedule ; Mass Vaccination/economics ; Mass Vaccination/trends ; Papillomavirus Infections/immunology ; Papillomavirus Vaccines/economics ; Young Adult
Czasopismo naukowe
Szczegóły
Tytuł:
Reliable surveillance of tick-borne encephalitis in European countries is necessary to improve the quality of vaccine recommendations.
Autorzy:
Stefanoff P; National Institute of Public Health-National Institute of Hygiene, Warsaw, Poland. />Polkowska A
Giambi C
Levy-Bruhl D
O'Flanagan D
Dematte L
Lopalco PL
Mereckiene J
Johansen K
D'Ancona F
Corporate Authors:
VENICE project gatekeepers, contact persons group
Źródło:
Vaccine [Vaccine] 2011 Feb 01; Vol. 29 (6), pp. 1283-8. Date of Electronic Publication: 2010 Dec 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Encephalitis, Tick-Borne/*epidemiology
Encephalitis, Tick-Borne/*prevention & control
Vaccination/*methods
Vaccination/*standards
Viral Vaccines/*immunology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Endemic Diseases/prevention & control ; Europe/epidemiology ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Szczegóły
Tytuł:
Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage.
Autorzy:
Kanitz EE; National Centre for Epidemiology, Surveillance and Health Promotion-CNESPS, Istituto Superiore di Sanità, Rome, Italy.
Wu LA
Giambi C
Strikas RA
Levy-Bruhl D
Stefanoff P
Mereckiene J
Appelgren E
D'Ancona F
Corporate Authors:
VENICE (Vaccine European New Integrated Collaboration Effort) National Gatekeepers, Contact Points
Źródło:
Vaccine [Vaccine] 2012 Jul 27; Vol. 30 (35), pp. 5222-8. Date of Electronic Publication: 2012 Jun 18.
Typ publikacji:
Journal Article
MeSH Terms:
Health Policy*
Immunization Programs/*statistics & numerical data
Vaccines/*administration & dosage
Adult ; European Union ; Humans ; Iceland ; Immunization Programs/methods ; Norway ; Surveys and Questionnaires
Czasopismo naukowe
Szczegóły
Tytuł:
Unequal access to vaccines in the WHO European Region during the A(H1N1) influenza pandemic in 2009.
Autorzy:
Jorgensen P; World Health Organization Regional Office for Europe, Copenhagen, Denmark. />Wasley A
Mereckiene J
Cotter S
Weber JT
Brown CS
Źródło:
Vaccine [Vaccine] 2013 Aug 28; Vol. 31 (38), pp. 4060-2. Date of Electronic Publication: 2013 Jul 08.
Typ publikacji:
Journal Article
MeSH Terms:
Influenza Vaccines*
Healthcare Disparities/*statistics & numerical data
Influenza A Virus, H1N1 Subtype/*pathogenicity
Influenza, Human/*epidemiology
Vaccination/*statistics & numerical data
Data Collection ; Europe/epidemiology ; Humans ; Immunization Programs/organization & administration ; Influenza, Human/virology
Czasopismo naukowe
Szczegóły
Tytuł:
Low vaccination coverage for seasonal influenza and pneumococcal disease among adults at-risk and health care workers in Ireland, 2013: The key role of GPs in recommending vaccination.
Autorzy:
Giese C; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Mereckiene J; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Danis K; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
O'Donnell J; HSE Health Protection Surveillance Centre, Dublin, Ireland.
O'Flanagan D; HSE Health Protection Surveillance Centre, Dublin, Ireland.
Cotter S; HSE Health Protection Surveillance Centre, Dublin, Ireland. Electronic address: .
Źródło:
Vaccine [Vaccine] 2016 Jul 12; Vol. 34 (32), pp. 3657-62. Date of Electronic Publication: 2016 Jun 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Health Personnel*
Vulnerable Populations*
Influenza Vaccines/*therapeutic use
Pneumococcal Vaccines/*therapeutic use
Vaccination/*statistics & numerical data
Adolescent ; Adult ; Aged ; Female ; Health Knowledge, Attitudes, Practice ; Humans ; Influenza, Human/prevention & control ; Ireland ; Male ; Middle Aged ; Pneumococcal Infections/prevention & control ; Surveys and Questionnaires ; Young Adult
Czasopismo naukowe
Szczegóły
Tytuł:
Tuberculosis contact investigations associated with air travel in Ireland, September 2011 to November 2014.
Autorzy:
Flanagan P; Health Protection Surveillance Centre, Dublin, Ireland.
O'Donnell J
Mereckiene J
O'Flanagan D
Źródło:
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2016 Oct 06; Vol. 21 (40).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Air Travel*
Aircraft*
Contact Tracing/*statistics & numerical data
Mycobacterium tuberculosis/*isolation & purification
Tuberculosis, Pulmonary/*diagnosis
Adult ; Contact Tracing/methods ; Disease Notification ; Female ; Humans ; Ireland ; Male ; Practice Guidelines as Topic ; Retrospective Studies ; Risk Factors ; Sputum/microbiology ; Tuberculin Test ; Tuberculosis, Pulmonary/epidemiology ; Tuberculosis, Pulmonary/transmission
Czasopismo naukowe
Szczegóły
Tytuł:
Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study.
Autorzy:
Savulescu C; Epidemiology Department, EpiConcept, Paris, France. Electronic address: .
Krizova P; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Lepoutre A; Infectious Disease Department, French National Agency for Public Health, Saint-Maurice, France.
Mereckiene J; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland.
Vestrheim DF; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; General Sub-Directorate for Surveillance and Public Health Emergency Response, Public Health Agency of Catalunya, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ordobas M; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain.
Guevara M; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK.
Morfeldt E; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
Kozakova J; Centre for Epidemiology and Microbiology, National Institute of Public Health, Prague, Czech Republic.
Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France.
Cotter S; Vaccine Preventable Disease Department, Health Protection Surveillance Centre, Dublin, Ireland.
Winje BA; Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain; Molecular Microbiology Department, Hospital Sant Joan de Déu, Barcelona, Spain; International University of Catalunya, Barcelona, Spain.
Garcia L; Sub-Directorate of Health Promotion and Prevention, Madrid, Spain.
Castilla J; Public Health Institute of Navarra-IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK.
Henriques-Normark B; Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden; Department of Microbiology, Tumour and Cell Biology, Karolinska Institute, Stockholm, Sweden; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Celentano LP; Office of Chief Scientist Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden.
Hanquet G; Epidemiology Department, EpiConcept, Paris, France.
Corporate Authors:
SpIDnet group
Źródło:
The Lancet. Respiratory medicine [Lancet Respir Med] 2017 Aug; Vol. 5 (8), pp. 648-656. Date of Electronic Publication: 2017 Mar 27.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Immunization Programs/*statistics & numerical data
Pneumococcal Infections/*epidemiology
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*therapeutic use
Child, Preschool ; Europe/epidemiology ; Female ; Humans ; Incidence ; Infant ; Male ; Outcome Assessment, Health Care ; Streptococcus pneumoniae/immunology
Czasopismo naukowe
Szczegóły
Tytuł:
The epidemiology of invasive pneumococcal disease in older adults in the post-PCV era. Has there been a herd effect?
Autorzy:
Corcoran M; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Vickers I; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Mereckiene J; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Murchan S; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Cotter S; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Fitzgerald M; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
McElligott M; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Cafferkey M; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
O'Flanagan D; Health Protection Surveillance Centre,Dublin,Gardiner Street,Dublin 1,Ireland.
Cunney R; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Humphreys H; The Irish Pneumococcal Reference Laboratory,Irish Meningitis and Sepsis Reference Laboratory,Temple Street Children's University Hospital,Temple Street,Dublin 1,Ireland.
Źródło:
Epidemiology and infection [Epidemiol Infect] 2017 Aug; Vol. 145 (11), pp. 2390-2399.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Pneumococcal Infections/*prevention & control
Pneumococcal Vaccines/*administration & dosage
Streptococcus pneumoniae/*immunology
Aged ; Aged, 80 and over ; Humans ; Ireland/epidemiology ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/microbiology
Czasopismo naukowe
Szczegóły
Tytuł:
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015.
Autorzy:
Jorgensen P; WHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark. Electronic address: .
Mereckiene J; Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
Cotter S; Health Protection Surveillance Centre, 25-27 Middle Gardiner Street, Dublin 1, Ireland.
Johansen K; European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden.
Tsolova S; European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 65 Solna, Sweden.
Brown C; WHO Regional Office for Europe, UN City, Marmorvej 51, 2100 Copenhagen, Denmark.
Źródło:
Vaccine [Vaccine] 2018 Jan 25; Vol. 36 (4), pp. 442-452. Date of Electronic Publication: 2017 Dec 26.
Typ publikacji:
Historical Article; Journal Article
MeSH Terms:
Influenza Vaccines*/administration & dosage
Influenza Vaccines*/immunology
Vaccination*
Vaccination Coverage*
Influenza, Human/*epidemiology
Influenza, Human/*prevention & control
Age Factors ; Europe/epidemiology ; European Union ; Female ; Geography, Medical ; Health Personnel ; Health Policy ; History, 21st Century ; Humans ; Immunization Programs ; Influenza, Human/history ; Male ; Population Surveillance ; Pregnancy ; Public Health Surveillance ; Seasons ; World Health Organization
Czasopismo naukowe
Szczegóły
Tytuł:
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination.
Autorzy:
Hanquet G; EpiConcept, Paris, France.; Antwerp University, Antwerp, Belgium.
Krizova P; National Institute of Public Health, Prague, Czech Republic.
Valentiner-Branth P; Statens Serum Institut, Copenhagen, Denmark.
Ladhani SN; Public Health England, London, UK.
Nuorti JP; National Institute for Health and Welfare, Helsinki, Finland.; University of Tampere, Tampere, Finland.
Lepoutre A; Santé publique France, Saint-Maurice, France.
Mereckiene J; Health Protection Surveillance Centre, Dublin, Ireland.
Knol M; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Winje BA; Norwegian Institute of Public Health, Oslo, Norway.
Ciruela P; Public Health Agency of Catalunya, Barcelona, Spain.; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Ordobas M; General Directorate of Public Health, Madrid, Spain.
Guevara M; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
McDonald E; Health Protection Scotland, National Services Scotland, Glasgow, UK.
Morfeldt E; Public Health Agency of Sweden, Solna, Sweden.
Kozakova J; National Institute of Public Health, Prague, Czech Republic.
Slotved HC; Statens Serum Institut, Copenhagen, Denmark.
Fry NK; Public Health England, London, UK.
Rinta-Kokko H; National Institute for Health and Welfare, Helsinki, Finland.
Varon E; National Centre for Pneumococci, European Hospital George Pompidou, Paris, France.
Corcoran M; Irish Pneumococcal Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.
van der Ende A; Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Amsterdam, The Netherlands.
Vestrheim DF; Norwegian Institute of Public Health, Oslo, Norway.
Munoz-Almagro C; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Recerca Pediátrica, Hospital Sant Joan de Deu, Universitat Internacional de Catalunya, Barcelona, Spain.
Latasa P; General Directorate of Public Health, Madrid, Spain.
Castilla J; CIBER Epidemiología y Salud Pública, Madrid, Spain.; Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain.
Smith A; Scottish Haemophilus, Legionella, Meningococcus and Pneumococcus Reference Laboratory, Glasgow, UK.
Henriques-Normark B; Public Health Agency of Sweden, Solna, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden.
Whittaker R; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Pastore Celentano L; European Centre for Disease Prevention and Control, Stockholm, Sweden.
Savulescu C; EpiConcept, Paris, France.
Corporate Authors:
SpIDnet/I-MOVE+ Pneumo Group
Źródło:
Thorax [Thorax] 2019 May; Vol. 74 (5), pp. 473-482. Date of Electronic Publication: 2018 Oct 24.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Pneumococcal Vaccines/*pharmacology
Streptococcus pneumoniae/*immunology
Vaccination/*methods
Aged ; Europe/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Retrospective Studies ; Serogroup
Czasopismo naukowe
Szczegóły
Wyświetlanie 1-25 z 82

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz